Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors
在接受免疫检查点抑制剂治疗的非小细胞肺癌患者中,循环中的IL-6而非其循环信号成分sIL-6R和sgp130具有临床意义。
期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2023.1324898
Nakahara, Yoshiro; Kouro, Taku; Motoyama, Satoru; Miura, Masatomo; Fujita, Kazuma; Igarashi, Yuka; Higashijima, Naoko; Matsuo, Norikazu; Himuro, Hidetomo; Wei, Feifei; Horaguchi, Shun; Tsuji, Kayoko; Mano, Yasunobu; Komahashi, Mitsuru; Saito, Haruhiro; Azuma, Koichi; Sasada, Tetsuro
肺癌
肿瘤
肿瘤免疫
信号转导
gp130
细胞生物学
IL-6
免疫/内分泌